<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0163945.ref020">
 <label>20</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Bonnet</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Guivarch</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Berard</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Combis</surname>
   <given-names>JM</given-names>
  </name>, 
  <name>
   <surname>Remy</surname>
   <given-names>AJ</given-names>
  </name>, 
  <name>
   <surname>Glibert</surname>
   <given-names>A</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients</article-title>. 
  <source>World journal of hepatology</source>. 
  <year>2014</year>;
  <volume>6</volume>(
  <issue>9</issue>):
  <fpage>660</fpage>â€“
  <lpage>9</lpage>. 
  <pub-id pub-id-type="doi">10.4254/wjh.v6.i9.660</pub-id>
  <?supplied-pmid 25276282?>
  <pub-id pub-id-type="pmid">25276282</pub-id>
 </mixed-citation>
</ref>
